AbbVie remained the top pharma TV ad spender with Humira in June, and Gilead Sciences continued its TV push for Biktarvy and Truvada. But one longtime list placeholder dropped out of sight: Pfizer’s ...
April was an impressive show of pharma TV ad strength even for long-standing top spender Humira. The AbbVie immunology med and megablockbuster topped the list in a big way this month with more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results